Praveen Tyle

Insider Reports History

Identity
Location
Rochester, NY
SEC record
Reporting signature
/s/ Melissa Tosca, Attorney-in-Fact
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Praveen Tyle:

Form 4 holding Director

Skye Bioscience, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
35,000
Estimated value
Report date
29 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

KIORA PHARMACEUTICALS INC

Security class
Stock Option (right to buy)
Shares / value
30,000
Estimated value
Report date
01 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Praveen Tyle

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .